Study S003212

Investigation of Safety, Tolerability and Pharmacokinetic Properties of Single Doses of Subcutaneous NNC0487-0111 in Chinese Participants With Overweight or Obesity.

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07121153
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: DOUBLE
Status: COMPLETED
Enrollment: 36
Start: 2025-08-11
Primary completion: 2025-12-20
Lead sponsor: Novo Nordisk A/S
Conditions: Overweight; Obesity
Interventions: DRUG:NNC0487-0111 A; DRUG:Placebo A
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1311-5582

Registered primary outcomes

Number of treatment emergent adverse events (TEAEs) [From NNC0487-0111 administration (Day 1) to completion of the end of study visit (Day 23)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.